D59G (p.Asp59Gly) variant of PAH (Phenylalanine-4-hydroxylase)

D59G (p.Asp59Gly) in PAH (Phenylalanine-4-hydroxylase) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.64 / 1. The record also includes published literature and structural context.

D59G (p.Asp59Gly) variant details